Skip to main content
Erschienen in: Clinical Rheumatology 11/2018

18.09.2018 | Original Article

Survival rate, causes of death, and risk factors in systemic sclerosis: a large cohort study

verfasst von: Xue Li, Yu-quan Qian, Na Liu, Rong Mu, Yu Zuo, Guo-chun Wang, Yuan Jia, Zhan-guo Li

Erschienen in: Clinical Rheumatology | Ausgabe 11/2018

Einloggen, um Zugang zu erhalten

Abstract

To investigate the clinical pattern, survival rate, causes of death and risk factors in a large cohort of Chinese Han patients with systemic sclerosis (SSc). Inpatients treated from 2002 to 2014 were included in this study. Patients were classified into diffuse cutaneous SSc (dcSSc), limited cutaneous SSc (lcSSc), and SSc-overlap syndrome groups. Data were analyzed using Chi-squared tests, Kaplan–Meier curves, log-rank tests, and Cox proportional hazards modeling. Among a total of 201 patients, dcSSc (50.2%) was the major subtype, followed by lcSSc (30.3%) and SSc-overlap (19.4%). Interstitial lung disease (ILD, 148/201, 74%) was the most frequent organ involvement. The overall survival rates were 98% and 95% at 5 and 10 years, respectively. The overall standard mortality ratio (SMR) was 2.22. The most common cause of death was ILD combined with infection (8/16, 50%), followed by kidney failure (2/16, 12.5%). On crude analysis, pulmonary hypertension, ILD, cardiac involvements, renal involvements, and digital ischemia were associated with poor prognosis. On multivariate analysis, pericardial effusion (p = 0.000) and digital ischemia (p = 0.016) were independent prognostic factors of death. The mortality rate of patients with SSc is mildly increased in comparison with the general population. ILD is the most common systemic involvement and the principal cause of death in SSc. Pericardial effusion and digital ischemia are independent factors associated with death.
Literatur
1.
Zurück zum Zitat LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15(2):202–205PubMed LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15(2):202–205PubMed
2.
Zurück zum Zitat Moinzadeh P, Aberer E, Ahmadi-Simab K, Blank N, Distler JHW, Fierlbeck G, Genth E, Guenther C, Hein R, Henes J, Herich L, Herrgott I, Koetter I, Kreuter A, Krieg T, Kuhr K, Lorenz HM, Meier F, Melchers I, Mensing H, Mueller-Ladner U, Pfeiffer C, Riemekasten G, Sárdy M, Schmalzing M, Sunderkoetter C, Susok L, Tarner IH, Vaith P, Worm M, Wozel G, Zeidler G, Hunzelmann N, and all participating DNSS centers (2015) Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis 74(4):730–737CrossRef Moinzadeh P, Aberer E, Ahmadi-Simab K, Blank N, Distler JHW, Fierlbeck G, Genth E, Guenther C, Hein R, Henes J, Herich L, Herrgott I, Koetter I, Kreuter A, Krieg T, Kuhr K, Lorenz HM, Meier F, Melchers I, Mensing H, Mueller-Ladner U, Pfeiffer C, Riemekasten G, Sárdy M, Schmalzing M, Sunderkoetter C, Susok L, Tarner IH, Vaith P, Worm M, Wozel G, Zeidler G, Hunzelmann N, and all participating DNSS centers (2015) Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis 74(4):730–737CrossRef
3.
Zurück zum Zitat Broen JC, Radstake TR, Rossato M (2014) The role of genetics and epigenetics in the pathogenesis of systemic sclerosis. Nat Rev Rheumatol 10(11):671–681CrossRef Broen JC, Radstake TR, Rossato M (2014) The role of genetics and epigenetics in the pathogenesis of systemic sclerosis. Nat Rev Rheumatol 10(11):671–681CrossRef
4.
Zurück zum Zitat Steen V, Domsic RT, Lucas M, Fertig N, Medsger TA Jr (2012) A clinical and serologic comparison of African-American and Caucasian patients with systemic sclerosis. Arthritis Rheum 64(9):2986–2994CrossRef Steen V, Domsic RT, Lucas M, Fertig N, Medsger TA Jr (2012) A clinical and serologic comparison of African-American and Caucasian patients with systemic sclerosis. Arthritis Rheum 64(9):2986–2994CrossRef
5.
Zurück zum Zitat Krzyszczak ME, Li Y, Ross SJ, Ceribelli A, Chan EKL, Bubb MR, Sobel ES, Reeves WH, Satoh M (2011) Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies. Clin Rheumatol 30(10):1333–1339CrossRef Krzyszczak ME, Li Y, Ross SJ, Ceribelli A, Chan EKL, Bubb MR, Sobel ES, Reeves WH, Satoh M (2011) Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies. Clin Rheumatol 30(10):1333–1339CrossRef
6.
Zurück zum Zitat Rubio-Rivas M, Royo C, Simeón CP, Corbella X, Fonollosa V (2014) Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum 44(2):208–219CrossRef Rubio-Rivas M, Royo C, Simeón CP, Corbella X, Fonollosa V (2014) Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum 44(2):208–219CrossRef
7.
Zurück zum Zitat Steen VD, Medsger TA (2007) Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 66(7):940–944CrossRef Steen VD, Medsger TA (2007) Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 66(7):940–944CrossRef
8.
Zurück zum Zitat Preliminary criteria for the classification of systemic sclerosis (scleroderma) (1980) Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23(5):581–590CrossRef Preliminary criteria for the classification of systemic sclerosis (scleroderma) (1980) Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23(5):581–590CrossRef
9.
Zurück zum Zitat Galie N, Hoeper MM, Humbert M et al (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 30(20):2493–2537CrossRef Galie N, Hoeper MM, Humbert M et al (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 30(20):2493–2537CrossRef
10.
Zurück zum Zitat Rubio-Rivas M, Corbella X, Pestañafernández M et al (2018) First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study. Clin Rheumatol 37(4):999–1009CrossRef Rubio-Rivas M, Corbella X, Pestañafernández M et al (2018) First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study. Clin Rheumatol 37(4):999–1009CrossRef
11.
Zurück zum Zitat Shu C, Du W, Mao X et al (2014) Possible single-nucleotide polymorphism loci associated with systemic sclerosis susceptibility: a genetic association study in a Chinese Han population. PLoS One 9(12):e113197CrossRef Shu C, Du W, Mao X et al (2014) Possible single-nucleotide polymorphism loci associated with systemic sclerosis susceptibility: a genetic association study in a Chinese Han population. PLoS One 9(12):e113197CrossRef
12.
Zurück zum Zitat Wang J, Guo X, Yi L, Guo G, Tu W, Wu W, Yang L, Xiao R, Li Y, Chu H, He D, Jin L, Mayes MD, Zou H, Zhou X (2014) Association of HLA-DPB1 with scleroderma and its clinical features in Chinese population. PLoS One 9(1):e87363CrossRef Wang J, Guo X, Yi L, Guo G, Tu W, Wu W, Yang L, Xiao R, Li Y, Chu H, He D, Jin L, Mayes MD, Zou H, Zhou X (2014) Association of HLA-DPB1 with scleroderma and its clinical features in Chinese population. PLoS One 9(1):e87363CrossRef
13.
Zurück zum Zitat Zhou XD, Yi L, Guo XJ, Chen E, Zou HJ, Jin L, Mayes MD, Assassi S, Wang JC (2013) Association of HLA-DQB1*0501 with scleroderma and its clinical features in Chinese population. Int J Immunopathol Pharmacol 26(3):747–751CrossRef Zhou XD, Yi L, Guo XJ, Chen E, Zou HJ, Jin L, Mayes MD, Assassi S, Wang JC (2013) Association of HLA-DQB1*0501 with scleroderma and its clinical features in Chinese population. Int J Immunopathol Pharmacol 26(3):747–751CrossRef
14.
Zurück zum Zitat Walker UA, Tyndall A, Czirják L et al (2007) Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis 66(6):754–763CrossRef Walker UA, Tyndall A, Czirják L et al (2007) Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis 66(6):754–763CrossRef
15.
Zurück zum Zitat Komocsi A, Vorobcsuk A, Faludi R et al (2012) The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies. Rheumatology 51(6):1027–1036CrossRef Komocsi A, Vorobcsuk A, Faludi R et al (2012) The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies. Rheumatology 51(6):1027–1036CrossRef
16.
Zurück zum Zitat Mecoli CA, Shah AA, Boin F, Wigley FM, Hummers LK (2018) Vascular complications in systemic sclerosis: a prospective cohort study. Clin Rheumatol 37(9):2429–2437CrossRef Mecoli CA, Shah AA, Boin F, Wigley FM, Hummers LK (2018) Vascular complications in systemic sclerosis: a prospective cohort study. Clin Rheumatol 37(9):2429–2437CrossRef
17.
Zurück zum Zitat Wangkaew S, Prasertwitayakij N, Phrommintikul A, Puntana S, Euathrongchit J (2017) Causes of death, survival and risk factors of mortality in Thai patients with early systemic sclerosis: inception cohort study. Rheumatol Int 37(12):2087–2094CrossRef Wangkaew S, Prasertwitayakij N, Phrommintikul A, Puntana S, Euathrongchit J (2017) Causes of death, survival and risk factors of mortality in Thai patients with early systemic sclerosis: inception cohort study. Rheumatol Int 37(12):2087–2094CrossRef
18.
Zurück zum Zitat Mihai C, Landewe R, van der Heijde D et al (2016) Digital ulcers predict a worse disease course in patients with systemic sclerosis. Ann Rheum Dis 75(4):681–686CrossRef Mihai C, Landewe R, van der Heijde D et al (2016) Digital ulcers predict a worse disease course in patients with systemic sclerosis. Ann Rheum Dis 75(4):681–686CrossRef
19.
Zurück zum Zitat Greiner S, Jud A, Aurich M, Hess A, Hilbel T, Hardt S, Katus HA, Mereles D (2014) Reliability of noninvasive assessment of systolic pulmonary artery pressure by Doppler echocardiography compared to right heart catheterization: analysis in a large patient population. J Am Heart Assoc 3(4):e001103CrossRef Greiner S, Jud A, Aurich M, Hess A, Hilbel T, Hardt S, Katus HA, Mereles D (2014) Reliability of noninvasive assessment of systolic pulmonary artery pressure by Doppler echocardiography compared to right heart catheterization: analysis in a large patient population. J Am Heart Assoc 3(4):e001103CrossRef
20.
Zurück zum Zitat Simeón CP, Armadans L, Fonollosa V, Solans R, Selva A, Villar M, Lima J, Vaqué J, Vilardell M (2003) Mortality and prognostic factors in Spanish patients with systemic sclerosis. Rheumatology 42(1):71–75CrossRef Simeón CP, Armadans L, Fonollosa V, Solans R, Selva A, Villar M, Lima J, Vaqué J, Vilardell M (2003) Mortality and prognostic factors in Spanish patients with systemic sclerosis. Rheumatology 42(1):71–75CrossRef
21.
Zurück zum Zitat Pérez-Bocanegra C, Solans-Laqué R, Simeón-Aznar CP et al (2010) Age-related survival and clinical features in systemic sclerosis patients older or younger than 65 at diagnosis. Rheumatology 49(6):1112–1117CrossRef Pérez-Bocanegra C, Solans-Laqué R, Simeón-Aznar CP et al (2010) Age-related survival and clinical features in systemic sclerosis patients older or younger than 65 at diagnosis. Rheumatology 49(6):1112–1117CrossRef
Metadaten
Titel
Survival rate, causes of death, and risk factors in systemic sclerosis: a large cohort study
verfasst von
Xue Li
Yu-quan Qian
Na Liu
Rong Mu
Yu Zuo
Guo-chun Wang
Yuan Jia
Zhan-guo Li
Publikationsdatum
18.09.2018
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 11/2018
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-018-4291-z

Weitere Artikel der Ausgabe 11/2018

Clinical Rheumatology 11/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.